GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

Nephrologists jumped on the GLP-1 bandwagon well before Novo Nordisk won FDA approval for Ozempic in chronic kidney disease ...

Ozempic and other GLP-1 agonists are helping millions with weight loss but concerns grow over their long-term effects. Recent ...

Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 ...

Most people know that GLP-1 receptor agonist medications like Ozempic and Wegovy ... Those included nausea and vomiting, kidney stones, gastroesophageal reflux disease (GERD), sleep issues ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...

Major stock indexes closed lower on Friday, after the week saw a flurry of events, including DeepSeek scare and earnings ...

A popular diabetes drug just got a major new approval -- and it could be a game-changer for millions of Americans at risk for kidney failure.

How the drugs might work Researchers don’t know how drugs like Ozempic might protect against ... including heart and kidney disease. The same dynamic may be happening in the brain: Inflammation ...

Recent studies highlight side effects such as heart muscle weakening and skin hypersensitivity, along with gastrointestinal issues, pancreatitis, and potential kidney damage. Ozempic and other GLP ...

Overweight with an ailing heart and kidney, Liebling died at the age of ... Weight-loss drugs such as Ozempic have been a breakthrough because they eliminate the need to cut back or compensate ...